Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t?

authors:

avatar Laleh Eslamian a , avatar Marjan Ahmadi a , * , avatar Mahnaz Ahmadi b

Department of Obstetrics and Gynecology, Perinatology Unit, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iranian Journal of Pharmaceutical Research : IJPR: Vol.20, issue 1; 1-2
article type: Letter to Editor
received: February , 2021
accepted: March , 2021
DOI: https://doi.org/10.22037/ijpr.2021.115076.15183

how to cite: Eslamian L, Ahmadi M, Ahmadi M. Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t?. Iran J Pharm Res. 2021;20(1):e124355. https://doi.org/10.22037/ijpr.2021.115076.15183.

References

  • 1.

    He XJ, Dai RX, Hu CL. Maternal prepregnancy overweight and obesity and the risk of preeclampsia: A meta-analysis of cohort studies. Obes. Res. Clin. Pract. 2020;14:27-33. [PubMed ID: 32035840].

  • 2.

    Benkő Z, Wright A, Rehal A, Cimpoca B, Syngelaki A, Delgado J, Tsokaki T, De Alvarado M, Vojtassakova D, Malligiannis Ntalianis K. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks’ gestation: data from EVENTS trial. Ultrasound Obstet. Gynecol. 2021;57:257-65. [PubMed ID: 33142361].

  • 3.

    Khalil A, Kalafat E, Benlioglu C, O’Brien P, Morris E, Draycott T, Thangaratinam S, Le Doare K, Heath P, Ladhani S, von Dadelszen P, Magee LA. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine. 2020;25:100446. [PubMed ID: 32838230].

  • 4.

    D’Souza R, Ashraf R, Rowe H, Zipursky J, Clarfield L, Maxwell C, Arzola C, Lapinsky S, Paquette K, Murthy S, Cheng MP, Malhamé I. Pregnancy and COVID-19: pharmacologic considerations. Ultrasound Obstet. Gynecol. 2021;57:195-203. [PubMed ID: 32959455].

  • 5.

    Halscott T, Vaught J. Society for maternal-fetal medicine management considerations for pregnant patients with COVID-19. SFMF Guideline. 2021;2021:26-7.

  • 6.

    Elwood C, Boucoiran I, VanSchalkwyk J, Money D, Yudin M, Poliquin V. Updated SOGC committee opinion – COVID-19 in pregnancy. J. Obstet. Gynaecol. Can. 2020:6-7.

  • 7.

    Royal College of Obstetricians, Gynaecologists. Coronavirus (COVID-19) infection in pregnancy. RCOG Guideline. 2020;2020:40-1.

  • 8.

    Giollo A, Adami G, Gatti D, Idolazzi L, Rossini M. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID). Ann. Rheum. Dis. 2020;80:e12. [PubMed ID: 32321720].